Print
Zogenix, Inc.
Cancels IPO
8/5/2008 7:36:51 AM
Zogenix Inc., a San Diego-based drug company focused on pain management and CNS disorders, has withdrawn registration for an $86.25 million IPO, citing "general market conditions."